0.00Open1.13Pre Close0 Volume2 Open Interest945.00Strike Price0.00Turnover7515.96%IV22.99%PremiumJan 3, 2025Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry1.13Extrinsic Value100Contract SizeAmericanOptions Type0.0366Delta0.0010Gamma680.76Leverage Ratio-4423.0324Theta0.0000Rho24.91Eff Leverage0.0009Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet